1. Home
  2. ICUCW vs NPACU Comparison

ICUCW vs NPACU Comparison

Compare ICUCW & NPACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • NPACU
  • Stock Information
  • Founded
  • ICUCW N/A
  • NPACU N/A
  • Country
  • ICUCW United States
  • NPACU United States
  • Employees
  • ICUCW 18
  • NPACU N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • NPACU Blank Checks
  • Sector
  • ICUCW Health Care
  • NPACU Finance
  • Exchange
  • ICUCW Nasdaq
  • NPACU Nasdaq
  • Market Cap
  • ICUCW N/A
  • NPACU N/A
  • IPO Year
  • ICUCW 2021
  • NPACU 2025
  • Fundamental
  • Price
  • ICUCW $0.05
  • NPACU $10.23
  • Analyst Decision
  • ICUCW
  • NPACU
  • Analyst Count
  • ICUCW 0
  • NPACU 0
  • Target Price
  • ICUCW N/A
  • NPACU N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • NPACU N/A
  • Earning Date
  • ICUCW N/A
  • NPACU N/A
  • Dividend Yield
  • ICUCW N/A
  • NPACU N/A
  • EPS Growth
  • ICUCW N/A
  • NPACU N/A
  • EPS
  • ICUCW N/A
  • NPACU N/A
  • Revenue
  • ICUCW N/A
  • NPACU N/A
  • Revenue This Year
  • ICUCW N/A
  • NPACU N/A
  • Revenue Next Year
  • ICUCW N/A
  • NPACU N/A
  • P/E Ratio
  • ICUCW N/A
  • NPACU N/A
  • Revenue Growth
  • ICUCW N/A
  • NPACU N/A
  • 52 Week Low
  • ICUCW N/A
  • NPACU N/A
  • 52 Week High
  • ICUCW N/A
  • NPACU N/A
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • NPACU N/A
  • Support Level
  • ICUCW N/A
  • NPACU N/A
  • Resistance Level
  • ICUCW N/A
  • NPACU N/A
  • Average True Range (ATR)
  • ICUCW 0.00
  • NPACU 0.00
  • MACD
  • ICUCW 0.00
  • NPACU 0.00
  • Stochastic Oscillator
  • ICUCW 0.00
  • NPACU 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About NPACU New Providence Acquisition Corp. III Units

New Providence Acquisition Corp III is a blank check company.

Share on Social Networks: